Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs
(4)Overall, this single-dose vaccine was locally and systemically well tolerated even after a two-dose repeat administration, confirming the high level of safety of ML29-SF vaccination and supporting the future evaluation of this LASV vaccine, including in clinical trials.
Authors
- Igor S. Lukashevich (ORCID: https://orcid.org/0000-0001-6523-5116)
- Irina Tretyakova
- Katie A. Albanese (ORCID: https://orcid.org/0000-0001-6282-541X)
- Dylan M. Johnson (ORCID: https://orcid.org/0000-0002-3630-0588)
- Peter Pushko (ORCID: https://orcid.org/0000-0002-1073-6981)
- Thomas L. Rudge (ORCID: https://orcid.org/0000-0002-8801-8744)
- Bradley S. Wahle
Institutions
- Battelle (US)
- University of Louisville (US)
- Sandia National Laboratories California (US)
- Medigen (United States) (US)
- MRIGlobal (US)
Publication Details
- Journal
- Future Pharmacology
- Published
- 2025-05-31
- DOI
- https://doi.org/10.3390/futurepharmacol5020026
- Citations
- 1
- Primary Topic
- Bacillus and Francisella bacterial research
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institutes of Health